semaglutide for aud Oral | Starts at $249/mo π¨ @TheLancet RCT: Weekly #semaglutide
Description
Hepatic Effects: Semaglutide has been shown to reduce liver fat content in patients with non-alcoholic fatty liver disease (NAFLD), possibly through improvements in insulin sensitivity and lipid metabolism
Upper GI Endoscopy Used to rule out cancer or mechanical obstruction
We also discuss combination therapies and strategies to mitigate muscle mass loss during treatment and calls for targeted research, improved clinical education, and policy reforms to optimize the translational potential of GLP-1R agonists in both individualized care and population health
It modulates central appetite and metabolic signaling through presynaptic transporter inhibition and hypothalamic regulation in experimental models
novel approaches are desirable
